(Note: gabapentin alone accounted for ~1.6% of all prescriptions in 2025)
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, characterized in research literature for its activity at the VEGF/VEGFR2-Akt-eNOS signaling axis and nitric oxide (NO) system modulation
Eur J Pharmacol (2019) 852:1424
A 20-unit injection from a 2.5mg/mL vial delivers 0.5mg of semaglutide
These may include: Although BPC157 and KPV are not currently FDA-approved for specific medical treatments, they are often discussed in regenerative and integrative medicine circles due to the strength of their preliminary research
Over time, that interest expanded into other areas, including muscle, tendon, ligament, and soft-tissue healing